Solid malignancies among etanercept-treated patients with granulomatosis with polyangiitis (Wegener's): Long-term followup of a multicenter longitudinal cohort Academic Article uri icon

Overview

MeSH Major

  • Granulomatosis with Polyangiitis
  • Immunoglobulin G
  • Neoplasms

abstract

  • The incidence of solid malignancy remained increased during long-term followup of the WGET cohort. However, this could not be attributed solely to etanercept exposure during the trial. Anti-TNF therapy with etanercept appears to further increase the risk of malignancy observed in patients with GPA treated with cytotoxic agents and should be avoided in these patients.

publication date

  • August 2011

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC3149780

Digital Object Identifier (DOI)

  • 10.1002/art.30394

PubMed ID

  • 21484770

Additional Document Info

start page

  • 2495

end page

  • 503

volume

  • 63

number

  • 8